Jonathan Bruce | Vice President, Market Access, Distribution, HEOR
F2G, Inc.

Jonathan Bruce is a seasoned biopharmaceutical executive with over two decades of experience in market access, pricing and contracting strategy, and patient services. As Vice President of Market Access, Distribution, HEOR, and Patient Services at F2G Inc., he leads initiatives to ensure patient access to innovative therapies, particularly in the rare infectious disease space. His expertise spans value-based pricing, payer engagement, distribution strategy, and HEOR, making him a key voice in navigating the evolving policy landscape for rare disease treatments. Throughout his career, Jonathan has played a pivotal role in shaping access strategies for rare disease and hospital-based therapies, holding leadership positions at Mallinckrodt Pharmaceuticals, Sanofi, and AstraZeneca. He has led teams responsible for designing patient-centric reimbursement models, market-shaping initiatives, and policy-driven access solutions, ensuring life-changing therapies reach the patients who need them most. Jonathan brings firsthand experience engaging with public and private payers, CMS, integrated delivery networks (IDNs), hospitals, and patient advocacy groups, making him an expert in bridging the gap between regulatory frameworks, commercialization strategies, and real-world patient impact. He holds an MBA in Marketing and Finance from Boston University and a Business Management and Genetics degree from the University of Vermont.